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Introduction
The unprecedented growth of the elderly population in the western world highlights the importance of studying the long-term outcomes of the interventions used for treatment of chronic conditions, including Urinary Incontinence (UI). In 2016, a large epidemiology study in the USA 1 showed prevalence in UI of 19-26% and increasing with age; this was most apparent for urgency urinary incontinence (UUI) and mixed urinary incontinence (MUI).
Interestingly, the prevalence of stress urinary incontinence (SUI) did not seem to increase with age in this study.
UI is associated with a negative impact on a woman's social, physical and psychological wellbeing, leading to embarrassment, low self-esteem, and negative effects on the productivity of working women. In extreme cases, patients reported avoiding employment; 60% avoided going away from home, and 50% avoided sexual activity 5, 6 and have rapidly gained wide popularity among surgeons due to the avoidance of the blind retro-pubic pathway. It was also hypothesised that TO-TVT could be preferred in women with MUI compared to retro-pubic tension-free vaginal tapes (RP-TVT) due to the more horizontal position of the tape and consequently, less postoperative OAB symptoms. Botros et al 7 compared RP-TVT vs TO-TVT in 276 women; and showed significantly lower rates of de-novo urgency incontinence and/ worsening of pre-existing urgency with TO-TVT with no significant difference in SUI cure rates. However, concerns were raised on the associated risk of chronic groin pain with TO-TVT.
There is a paucity of data on the long-term outcomes of TO-TVT. In the UK, the National Institute for Health and Clinical Excellence (NICE), the Cochrane review in 2015, and most recently the European review (SCENIHR) on surgical meshes in urogynaecological surgery 4, 8, 9 have all highlighted the lack of long-term outcomes data for MUS in general and TO-TVT in particular. They emphasized the importance of directing future research to address this significant gap in the literature. This study helps to bridge this gap in the literature, and follows up on the previously reported 1-year and 3-year outcomes of women with MUI from the E-TOT study 10, 11 .
Materials and Methods
This is a secondary analysis of the E-TOT study, a prospective single-blinded . At one, three and nine years follow-up, women completed the above questionnaires and in addition, the Patient Global Impression of Improvement (PGI-I)
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, the International Consultation on Incontinence Questionnaire-Short form (ICIQ-SF) 16 and questions on further continence surgery and adverse events.
Outcome measures:
The primary outcome measured was the patient-reported success rate defined as "very much improved" or "much improved" on the PGI-I, with all the other five responses classified as unsuccessful. In addition, all women who received further continence surgery were considered as failures. Secondary outcomes included improvement in quality of life (QoL) (≥18 points improvement in KHQ score)
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, impact on sexual function (change in PISQ-12 score), impact on pre-operative urgency and urgency incontinence (cure was defined as ≥2 point improvement on the relevant BBUSQ-22 questions) and late adverse events such as groin/thigh pain and mesh erosions.
Statistical analysis was performed using SPSS version 23. Chi-squared or Fisher's exact tests were used to compare categorical variables. Within-group comparisons of KHQ scores and PISQ-12 scores were analysed using the Wilcoxon signed rank test while between-group comparisons were analysed using the Mann-Whitney U test. The results of the PGI-I at 9-year follow-up were compared to that of 3-year and 1-year follow-ups using
McNemar's test, at the Bonferroni corrected significant level of 0.025. All other statistical analyses were performed at a 5% significance level. Intention-to-treat (ITT) analysis will be presented for the primary outcome with/ without considering women who underwent further continence surgery as failures. Multiple sensitivity analyses were performed for those who were lost to follow-up.
Results
Eighty-three women with pre-operative urodynamic MUI and predominant SUI symptoms were randomised; 7 women were excluded (deceased n=2 and withdrawn n=5); 48
women completed the follow-up at nine years (Outside-in n=29 vs. Inside-out n=19); adjusted response rate of 63% ( Figure 1 ). The baseline characteristics of the patients with MUI are presented in Table 1 .
Patient-reported success rate: On considering women who had further continence surgery as failures, the corrected patient-reported success rate was 64.6% with a further 14.6% (n=7) who reported "improved". There was no significant difference between groups (Outside-in 65.5% vs Inside-out 63.2%, OR 1.11, 95% CI 0.33 to 3.70, p>0.999) ( Table 2) . A sensitivity analysis was performed assuming the women lost to follow-up as failures, as successes, and based on their last observation carried forward (LOCF) and is presented in Table 2 .
There was a trend towards a drop in the patient-reported success rate over the years ( Figure 2 was a trend towards a drop in the OAB cure rates over the 9-years ( Figure 2 ). Women with cured Urgency had significantly higher patient-reported success rate compared to those with persistent/worsened symptoms (87.5% vs. 50%, p=0.029).
Late adverse events:
Chronic groin/ leg pain was reported in one patient (2%) at nine years in the Outside-in group. There were no reports of mesh extrusion or erosion in this group.
Impact on QoL:
Thirty-four women (70.8%) completed the KHQ questionnaires at 9-year follow-up. There were statistically significant decreases (improvement) in scores from baseline in all domains of the KHQ, with the exception of general health ( Impact on sexual function: Twenty-one women (43.8%) were sexually active and completed the PISQ-12 sexual function questionnaire at the 9-year follow-up, however only 16 were sexually active at both baseline and 9-year follow-up time points. 62.5% (n=10)
showed an increase of ≥1 point in PISQ-12 scores, indicating an improvement of sexual function (Table 3) .
Discussion:
This is the longest follow-up study reporting on the long-term outcomes of TO-TVT on women with MUI. Results showed patient-reported success rate of 64.6% at median of 9-years follow-up with further 14.6% reporting improvement. It was reassuring to see that the results did not change significantly on sensitivity analysis using last observation carried forward. In-addition, 85.3% of women reported clinically significant improvement in their QoL which gives us more confidence in the results. It was reassuring to see that 34.8% of women were cured of their pre-operative urgency and 40.9% were cured of UUI, while a small proportion (6.5% and 2.3%) had worsening symptoms respectively; women with cured OAB symptoms had significantly higher patient-reported success rate on PGI-I. However, the lack of randomisation and the retrospective nature allows for selection and recall bias respectively.
The success rate in our study declined over the years, from 74.7% to 73.8% to 64.6%
10,11
; the decline was not found to be statistically significant. The results are in line with the Cochrane review by Ford et al. Only one systematic review and meta-analysis reported on the effectiveness of MUS in women with MUI. However, they only found relatively small trials that reported up to medium-term outcomes (mean 34.9 ± 22.9 months)
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. The authors reported that MUS are associated with an overall success rate of 56.4% in women with MUI and were more effective in treating the stress component (85-97% success) than the urgency component (28-85% success).
Our results showed that the majority of women still reported OAB symptoms at 9-years.
It's well recognized that OAB symptoms tend to wax and wane and the incidence increase with age
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. Jahanlu and Hunskaar45 years over 10 years period and showed that 40% developed new onset UI; 50%, 18.3% and 20.3% for stress (SUI), urgency (UUI) and mixed urinary incontinence (MUI), respectively. Hence on assessing urgency at long-term follow-up studies, it can be difficult to ascertain if it's related to the MUS or the advancing age or is a progression of an underlying pathology.
Reassuringly, 35% and 41% of women achieved our pre-defined definition of cure for urgency and UUI at median of 9-years respectively (≥ 2 points improvement on the urgency questions for the BBUQ-22). Understandably, women with cured OAB symptoms had significantly higher patient-reported success rates on PGI-I. Our results were lower than Lee et al.
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, who showed 65.5% and 63.6% resolution rate of urgency and UUI respectively at 50- 
Strengths and limitations
This study has a number of strengths: the longest reported follow-up on women with MUI; the follow-up by postal questionnaire eliminates the risk of detection bias; and the use of validated questionnaires for assessing the outcomes. However, we acknowledge the limitations of the results; one of which is the sizeable loss to follow-up despite attempts to minimise attrition. As a secondary analysis of a larger RCT, the sample size was not adequately powered to detect a difference between the two types of TO-TVT procedures and leaves it vulnerable to a type II error. Nevertheless, the results will be quite important for relevant meta-analyses. The lack of objective assessment can be seen as a limitation; however the research community is increasingly recognising patient-reported outcome measures as more clinically relevant 32 .
Conclusion
This is the first study to report the long-term outcomes of TO-TVT in women with urodynamic MUI; TO-TVT operations are associated with a good and sustained patientreported success rate in women with MUI, up to nine years of follow-up. 40% of women were cured of urgency incontinence. 
